The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model
Erik R. Sampson(Legacy Health), Randy N. Rosier(University of Rochester)
Cited by 49
Related Papers
No related papers found
Powered by citation graph analysis